Nektar Therapeutics

(NKTR) Trade

By |

Profile

Nektar Therapeutics Inc is a biopharmaceutical company engaged in the development of new molecules to treat diseases with unmet medical needs. The company is researching and developing drugs for treating cancer, auto-immune disease and chronic pain.

Contact Information

Website: www.nektar.com
Email: Investors@nektar.com
Main Phone: +1 415 482-5300
Address: 455 Mission Bay Boulevard South
State: CA
City / Town: San Francisco
Country: USA
Postal Code: 94158

Issuer Information

Exchange: NGS
CEO: Howard W. Robin
Employees: 509
NAICS: Pharmaceutical Preparation Manufacturing (325412)
$ 47.79 $ 0.12 (0.25%)
Last Price 47.79 Change $ 0.12 Change % 0.25 Tick N/A
Bid 47.41 Bid Size 100.00 Ask 49.45 Ask Size 700.00
Open 47.50 High 48.04 Low 46.88 Prev Close 47.67
Last Trade Volume 1.9 mi 52 Wk Hi 111.36 52 Wk Low 17.51
Market Cap 8.2 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 171,402,476.00 EPS (TTM) -0.83 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 54 154
Number of Buys 27 78
Number of Sells 27 76
Net Activity 1280 285373
Last 10 Buys Shares
Roy A. Whitfield 1,000
Roy A. Whitfield 1,000
Roy A. Whitfield 1,000
Roy A. Whitfield 1,000
R. Scott Greer 1,000
Dennis L. Winger 1,000
Last 10 Sell Shares
R. Scott Greer 1,000
Robert B. Chess 1,000
R. Scott Greer 1,000
John Nicholson 1,000
Jillian B. Thomsen 1,000
Howard W. Robin 1,000
Stephen K. Doberstein 1,000
Maninder Hora 1,000
Gil M. Labrucherie 1,000
Robert B. Chess 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 125 125 125 125
Low Target Price Estimate 63 63 63 54
Mean Target Price Estimate 98.22 102.67 102.67 93.44
Standard Deviation 19.08 19.72 19.72 24.14
Date of Most Recent Estimate 06/04/18 05/16/18 05/16/18 06/11/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 8 9 8 6
Moderate Buy 0 0 0 0
Hold 2 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.4 1.2 1.22 1.29